Surgical resection and transplantation for hepatocellular carcinoma.

Resection or Transplant in Early Hepatocellular Carcinoma. Dtsch Arztebl Int (2017) 0.75

Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg (1994) 4.24

Periampullary tumors: which ones should be resected? Am J Surg (1985) 1.85

Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach. Surgery (1985) 1.63

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet (1997) 1.55

Diagnosis and management of hydatid disease of the liver. A 15-year North American experience. Ann Surg (1984) 1.55

Liver transplantation for hepatocellular carcinoma. Ann Surg (2001) 1.46

Delta and conjugated bilirubin as complementary markers of early rejection in liver-transplant recipients. Clin Chem (1990) 1.44

A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg (1997) 1.41

ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Mol Cell Biol (1996) 1.39

Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet (1987) 1.37

Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology (1985) 1.35

Treatment of primary liver graft nonfunction with prostaglandin E1. Transplantation (1989) 1.34

Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl (2000) 1.32

Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center. Am J Transplant (2007) 1.30

Complications after peritoneovenous shunting for ascites. Am J Surg (1980) 1.26

Treatment before liver transplantation for HCC. Ann Surg Oncol (2008) 1.22

A prospective randomized trial of the selective distal splenorenal shunt. Surg Gynecol Obstet (1980) 1.20

Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg (1995) 1.20

Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience. Am J Transplant (2010) 1.16

Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology (1996) 1.16

Reliability and validity of the objective structured clinical examination in assessing surgical residents. Am J Surg (1990) 1.15

Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest (1989) 1.15

Quantitative effects of Nf1 inactivation on in vivo hematopoiesis. J Clin Invest (2001) 1.14

Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. Ann Surg (2000) 1.14

Nonparasitic cysts of the liver. The case for conservative surgical management. Ann Surg (1987) 1.14

Reduced mortality with right-lobe living donor compared to deceased-donor liver transplantation when analyzed from the time of listing. Am J Transplant (2007) 1.13

Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med (1991) 1.13

Surgical management of hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg (1999) 1.10

Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg (1996) 1.05

Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. Can Med Assoc J (1982) 1.01

Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease. Am J Med (1994) 1.01

Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. Clin Oncol (R Coll Radiol) (2006) 0.98

Reconstruction of middle hepatic vein of a living-donor right lobe liver graft with recipient left portal vein. Transplantation (2001) 0.98

Iatrogenic bile-duct strictures. Can J Surg (1982) 0.97

Venovenous bypass in adult orthotopic liver transplantation: routine or selective use? J Am Coll Surg (1998) 0.96

Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. Ann Surg (1992) 0.96

Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology (2000) 0.95

Complete foregut duplication. Ann Thorac Surg (1990) 0.95

The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites. Gastroenterology (1979) 0.94

Management of patients with polyps containing malignancy removed by colonoscopic polypectomy. Dis Colon Rectum (1984) 0.93

Renal and hemodynamic effects of the peritoneovenous shunt. II. Long-term effects. Gastroenterology (1981) 0.92

General surgery training in Canada: are we in trouble? Can J Surg (1992) 0.92

Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. AJR Am J Roentgenol (1983) 0.92

Myeloid malignancies induced by alkylating agents in Nf1 mice. Blood (1999) 0.92

Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B. Am J Pathol (1992) 0.91

The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology (1993) 0.91

Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies. Genomics (2001) 0.91

Peliosis hepatis with intrahepatic calcifications. J Ultrasound Med (1996) 0.91

Liver transplantation for hepatocellular carcinoma. Am J Surg (1994) 0.89

A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation (1996) 0.89

Aggressive surgical management of fibrolamellar hepatocellular carcinoma. J Gastrointest Surg (2006) 0.88

Selective use of older adults in right lobe living donor liver transplantation. Am J Transplant (2007) 0.87

Experience with radical esophagogastric devascularization procedures (Sugiura) for variceal bleeding outside Japan. World J Surg (1994) 0.87

Living vs. deceased donor liver transplantation provides comparable recovery of renal function in patients with hepatorenal syndrome: a matched case-control study. Am J Transplant (2014) 0.86

Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series. Ann Surg Oncol (2014) 0.86

In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells. Blood (1999) 0.86

Bile duct injury. Results of repair using a changeable stent. Am J Surg (1973) 0.85

Donor-specific factors predict graft function following liver transplantation. Transplant Proc (1990) 0.85

Lymphoproliferative disorders after liver transplantation: imaging features. Abdom Imaging (2001) 0.83

Rat phenol-preferring sulfotransferase genes (Stp and Stp2): localization to mouse chromosomes 7 and 17. Genomics (1995) 0.82

The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients. J Gastrointest Surg (2001) 0.82

Brief report: combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous beta-thalassemia. N Engl J Med (1994) 0.82

Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma. Br J Surg (2013) 0.82

Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation. Transplantation (1994) 0.82

Prediction of the outcome of transplantation in man by platelet adherence in donor liver allografts. Evidence of the importance of prepreservation injury. Transplantation (1993) 0.81

The University of Toronto liver transplant program. Clin Transpl (1996) 0.81

Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma. Br J Surg (2013) 0.81

Acute reactant cytokines and neutrophil adhesion after warm ischemia in cirrhotic and noncirrhotic human livers. Hepatology (1996) 0.81

Liver transplantation in children: the initial Toronto experience. J Pediatr Surg (1989) 0.80

A comparison of acute reversible pre- and postsinusoidal portal hypertension on salt and water retention in the dog. Hepatology (1982) 0.80

Lamivudine for hepatitis B in liver transplantation: a single-center experience. Transplantation (2000) 0.80

Residency education in surgery. Can J Surg (2001) 0.79

Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation. Transplantation (1999) 0.79

Late graft loss following liver transplantation. Transplant Proc (1997) 0.79

Emergency surgical treatment of variceal hemorrhage. Surg Clin North Am (1990) 0.78

Genomic structure of rat liver aryl sulfotransferase IV-encoding gene. Gene (1993) 0.78

Prostaglandin E1 for primary nonfunction following liver transplantation. Transplant Proc (1989) 0.78

Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting. Gastroenterology (1983) 0.78

Early experience with reduced-size liver transplants. J Pediatr Surg (1990) 0.78

Geographical overlap of two mitochondrial genomes in Spanish honeybees (Apis mellifera iberica). J Hered (1991) 0.78

Current surgical management of primary hepatocellular carcinoma. Adv Surg (1999) 0.78

Needle biopsy of skeletal muscle using suction. Surg Gynecol Obstet (1985) 0.78

Natural history of recurrent hepatitis C after liver transplantation. Transplant Proc (2001) 0.77

Rapid donor liver nutritional enhancement in a large animal model. Hepatology (1992) 0.77

Liver transplantation for acute and subacute fulminant hepatic failure. Transplant Proc (1989) 0.77

Systemic hypotension and decreased pressor response in dogs with chronic bile duct ligation. Hepatology (1986) 0.77

Lipid-associated total parenteral nutrition in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr (1988) 0.76

Outcome of kidney transplantation alone versus synchronous pancreas-kidney transplantation in type 1 diabetics. Transplant Proc (1998) 0.76